Gen Z is leading a new weight loss trend: Ozempic microdosing

By Newsweek   |   1 month ago
Gen Z is leading a new weight loss trend: Ozempic microdosing

A growing number of Americans, especially Gen Z, are microdosing GLP-1 medications like Ozempic for weight loss and cost-saving benefits. Despite some users regretting it, microdosing has become a trend to manage weight and side effects more sustainably.

Read More

Did you find this insightful?